Your browser doesn't support javascript.
loading
Extensively drug-resistant Acinetobacter baumannii co-producing VIM-2 and OXA-23 in intensive care units: Results of a one-day point prevalence in a Tunisian hospital.
Ferjani, Sana; Kanzari, Lamia; Maamar, Elaa; Hamzaoui, Zaineb; Rehaiem, Amel; Ferjani, Asma; Boutiba-Ben Boubaker, Ilhem.
Afiliação
  • Ferjani S; University of Tunis El Manar, Faculty of Medicine of Tunis, LR99ES09, 1007, Tunis Tunisia. Electronic address: ferjsana@yahoo.fr.
  • Kanzari L; University of Tunis El Manar, Faculty of Medicine of Tunis, LR99ES09, 1007, Tunis Tunisia; Charles Nicolle Hospital, Laboratory of Microbiology, Boulevard 9 Avril, Tunis 1006, Tunisia.
  • Maamar E; University of Tunis El Manar, Faculty of Medicine of Tunis, LR99ES09, 1007, Tunis Tunisia.
  • Hamzaoui Z; University of Tunis El Manar, Faculty of Medicine of Tunis, LR99ES09, 1007, Tunis Tunisia.
  • Rehaiem A; University of Tunis El Manar, Faculty of Medicine of Tunis, LR99ES09, 1007, Tunis Tunisia; Charles Nicolle Hospital, Laboratory of Microbiology, Boulevard 9 Avril, Tunis 1006, Tunisia.
  • Ferjani A; University of Tunis El Manar, Faculty of Medicine of Tunis, LR99ES09, 1007, Tunis Tunisia; Charles Nicolle Hospital, Laboratory of Microbiology, Boulevard 9 Avril, Tunis 1006, Tunisia.
  • Boutiba-Ben Boubaker I; University of Tunis El Manar, Faculty of Medicine of Tunis, LR99ES09, 1007, Tunis Tunisia; Charles Nicolle Hospital, Laboratory of Microbiology, Boulevard 9 Avril, Tunis 1006, Tunisia.
Infect Dis Now ; 52(8): 426-431, 2022 Nov.
Article em En | MEDLINE | ID: mdl-36113767

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Infecções por Acinetobacter / Acinetobacter baumannii Tipo de estudo: Guideline / Prevalence_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Infecções por Acinetobacter / Acinetobacter baumannii Tipo de estudo: Guideline / Prevalence_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article